Dr. Defrancisco is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
13001 E 17th Pl
Stop
Aurora, CO 80045Phone+1 303-724-6019Fax+1 212-420-2181
Education & Training
Icahn School of Medicine at Mount Sinai (Beth Israel)Residency, Psychiatry, 2015 - 2019
Drexel University College of MedicineClass of 2015
University of ColoradoFellowship, Addiction Psychiatry
Certifications & Licensure
CO State Medical License 2019 - 2025
NY State Medical License 2017 - 2020- American Board of Psychiatry and Neurology Psychiatry
- American Board of Psychiatry and Neurology Addiction Psychiatry
Publications & Presentations
PubMed
- 9 citationsThe Relevance of Sex in the Association of Synthetic Cannabinoid Use With Psychosis and Agitation in an Inpatient Population.Anahita Bassir Nia, Claire L. Mann, Sharron Spriggs, Daniel DeFrancisco, Steven Carbonaro
The Journal of Clinical Psychiatry. 2019-07-02 - 3 citationsCannabis use is associated with low plasma endocannabinoid Anandamide in individuals with psychosis.Anahita Bassir Nia, Claire L Gibson, Sharron A Spriggs, Samantha E Jankowski, Daniel DeFrancisco
Journal of Psychopharmacology. 2023-05-01 - 10 citationsCannabinoid use in psychotic patients impacts inflammatory levels and their association with psychosis severity.Claire L. Gibson, Anahita Bassir Nia, Sharron Spriggs, Daniel DeFrancisco, Amy Swift
Psychiatry Research. 2020-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
